Article
Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.
Cell reports - 22 Dec 2015
Jin Jing, Liss Nathan M, Chen Dong-Hua, Liao Maofu, Fox Julie M, Shimak Raeann M, Fong Rachel H, Chafets Daniel, Bakkour Sonia, Keating Sheila, Fomin Marina E, Muench Marcus O, Sherman Michael B, Doranz Benjamin J, Diamond Michael S, Simmons Graham
Abstract excerpt
We evaluated the mechanism by which neutralizing human monoclonal antibodies inhibit chikungunya virus (CHIKV) infection. Potently neutralizing antibodies (NAbs) blocked infection at multiple steps of the virus life cycle, including entry and release. Cryo-electron microscopy structures of Fab fragments of two human NAbs and chikungunya virus-like particles showed a binding footprint that spanned independent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
